Uso de ansiolíticos e hipnóticos durante el embarazo y la lactancia

  1. Maider Prieto 1
  2. Rodrigo Oraá 2
  3. M. José Zardoya 3
  4. José J. Uriarte 2
  5. Pablo Malo 4
  6. Juan Medrano 2
  7. Luis Pacheco 2
  1. 1 Hospital de Zamudio
  2. 2 Instituto de Investigación Sanitaria Biocruces Bizkaia
    info

    Instituto de Investigación Sanitaria Biocruces Bizkaia

    Barakaldo, España

    ROR https://ror.org/0061s4v88

  3. 3 Hospital Universitario de Cruces-Barakaldo
  4. 4 Red de Salud Mental de Bizkaia
Show affiliations +
Journal:
Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica

ISSN: 1134-5934

Year of publication: 2018

Volume: 25

Issue: 1

Pages: 7-11

Type: Article

DOI: 10.1016/J.PSIQ.2018.01.004 DIALNET GOOGLE SCHOLAR

More publications in: Psiquiatría biológica: Publicación oficial de la Sociedad Española de Psiquiatría Biológica

Sustainable development goals

Abstract

A review is presented on the use of anxiolytics and hypnotics during pregnancy and lactation. An analysis is made on their teratogenic effect, as well as the associated perinatal syndromes and the possible effects on the development of the newborn child. It is concluded that the evidence from the studies is insufficient to ensure that their use is safe, although it seems that there are few complications. In general, efforts should be made to avoid the use of benzodiazepines during the first trimester, especially in weeks 3 to 11, due to the increased risk of teratogenicity, and provided that another alternative is available and considered effective. They can be used if there is no feasible and better pharmacological or non-pharmacological alternative, and there is a clinical indication.

Data source: Dialnet